Aspire BioPharma, Inc. (ASBP) — Financial Flexibility Index
Aspire BioPharma, Inc. (ASBP) has a Financial Flexibility Index of -0.12x as of December 2025. Free cash flow of $-927.84K (operating CF $-927.84K minus capex $0.00) represents 0% of total liabilities ($7.69 Million). Also explore Aspire BioPharma, Inc. annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aspire BioPharma, Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Aspire BioPharma, Inc. across 5 annual periods. See Aspire BioPharma, Inc. (ASBP) net asset quality to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Aspire BioPharma, Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Aspire BioPharma, Inc.. For the full company profile including market capitalisation, see market cap of Aspire BioPharma, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.64x | $-4.92 Million | $-4.92 Million | $7.69 Million | ▼ -307.6% |
| 2024 | -0.16x | $-265.19K | $-265.19K | $1.69 Million | ▲ +90.3% |
| 2023 | -1.62x | $-653.10K | $-653.11K | $403.33K | ▼ -1177.7% |
| 2022 | -0.13x | $-1.41 Million | $-1.41 Million | $11.12 Million | ▼ -14216.2% |
| 2021 | 0.00x | $-260.00 | $-260.00 | $293.70K | — |